All the data for this paper is available from the following sources: the genome is available from NCBI (BioProject ID: PRJNA222831) and proteomic analysis is available from UniProt (entry CAMJE).

Introduction {#sec001}
============

*Campylobacter jejuni* is an important pathogen causing significant morbidity and mortality. *C*. *jejuni* is a Gram-negative, comma-shaped, microaerophilic bacterium, and is motile by means of unipolar or bipolar flagella. The genus *Campylobacter* was proposed in 1963, separating these bacteria from *Vibrio*-like organisms based on morphology, DNA composition, microaerobic growth requirement, and non-fermentive metabolism \[[@pone.0118533.ref001]\]. *C*. *jejuni* was first isolated from human feces in 1972 \[[@pone.0118533.ref002]\]. Human infection, also called campylobacteriosis, often occurs after handling or ingesting food contaminated by raw poultry products. Clinical infection with *C*. *jejuni* presents as diarrhea with blood and leukocytes, fever, nausea, and severe abdominal cramps that occur 2--5 days following ingestion \[[@pone.0118533.ref003], [@pone.0118533.ref004]\]. In recent years, infection rates with *Campylobacter* spp. has been comparable to or has exceeded that of other enteric pathogens, including *Salmonella* spp. and *Shigella* spp. The highest prevalence of *Campylobacter*-mediated disease is among children less than 5 years of age \[[@pone.0118533.ref005]\]. Trials with human volunteers have demonstrated that the infectious dose of *C*. *jejuni* is as few as 500 organisms, although there is no clear correlation between dose and disease severity. Although campylobacteriosis is usually self-limiting, erythromycin and azithromycin can be used to treat individuals with severe enteritis. Infection with some *C*. *jejuni* isolates correlates with a higher incidence of Guillain-Barré syndrome (GBS), an autoimmune disease and the most common cause of flaccid paralysis in the post-polio era \[[@pone.0118533.ref006]\]. The association between *C*. *jejuni* infections and GBS is due to molecular mimicry resulting in a cross-reactive immune response between *Campylobacter* lipo-oligosaccharides (LOS) and neural gangliosides \[[@pone.0118533.ref007], [@pone.0118533.ref008]\]. In the United States, treatment of *C*. *jejuni* infections and GBS is estimated to cost \$1.2 billion per year.

Advances in sequencing technology have resulted in an increase in the number of *C*. *jejuni* genomes available to researchers \[[@pone.0118533.ref007], [@pone.0118533.ref009], [@pone.0118533.ref010]\]. Deciphering the *C*. *jejuni* pan genome, which is comprised of both the core and variable genes, coupled with the epidemiology and ecology data has led to a deeper understanding of the genomic content and how this can influence the environmental niche and transmission of individual isolates. For example, comparative genomic analysis has demonstrated variability in the genomic content of *C*. *jejuni* strains, possibly influenced by the host from which the isolate was recovered (*e*.*g*., human, chicken, ruminant, etc.) and geographical location. More specifically, the genomes of *C*. *jejuni* human isolates are more similar to non-livestock isolates (environmental) than to livestock isolates, as assessed by DNA microarray analysis of whole-genome comparisons of 111 isolates \[[@pone.0118533.ref011]\]. This type of analysis will also allow for improved risk-based approaches for implementing efficient *C*. *jejuni*-mediated disease control measures in the environment, at the farm, and in retail consumer meat \[[@pone.0118533.ref012], [@pone.0118533.ref013]\].

Methylation of the genome plays important biological roles in bacteria. Several decades ago it was determined that methylation is an important component of restriction-modification (RM) systems that prevent foreign DNA, including phage DNA, from integrating into the bacterial genome. The DNA in the host is marked through sequence-specific methylation of adenine and cytosine nucleotides. Most RM systems fall into one of four categories, Types I---IV, although non-classical RM systems have been discovered that are not as easily categorized \[[@pone.0118533.ref014]\]. Classification is based on the number of genes/subunits, methylation and restriction activities performed, co-factors required for activity, recognition sequence, cleavage site, and mechanism of cleavage. Type I RM systems are composed of three different enzymes, designated R, S or M, which are responsible for endonuclease activity, determining the sequence specificity of methylation and cleavage, and methylation of the DNA substrate, respectively. The recognition sequence is both bipartite and asymmetrical with cleavage occurring at variable locations within approximately 1 kilobase from the recognition site. Methylation usually occurs at the N^6^ position of adenines within the recognition site. Type I RM systems are widespread in prokaryotes, including *C*. *jejuni*, where 53 out of 73 *C*. *jejuni* strains tested contained Type I RM loci \[[@pone.0118533.ref015]\]. Type II RM systems are the most characterized RM systems and are usually comprised of separate restriction endonuclease and methylase enzymes, although there are examples of both activities being performed by a single enzyme. The restriction endonuclease component usually forms a homodimer, while the methylase is a monomer. Both enzymes recognize an identical DNA sequence, which is typically a 4--8 base pair palindrome. Type III RM systems are comprised of two separate enzymes and recognize 5--6 base pair asymmetric sequences, with cleavage occurring at a fixed location within approximately 25 base pairs of the recognition sequence. Type IV RM systems do not modify DNA and only cleave DNA that contains methylated, hydroxymethylated, or glucosyl-hydroxymethylated cytosines. Other methylases include Dam and Dcm. Dam methylates the N^6^ position of adenine in the sequence GATC, while Dcm methylates cytosines at the C^5^ position of the sequences CCAGG and CCTGG. In addition to these functions, methylation in bacteria has also been shown to influence DNA replication, DNA repair, gene transcription, the transfer of plasmids, and mutations in methylases influence virulence \[[@pone.0118533.ref016]\].

The *C*. *jejuni* F38011 strain was isolated from an individual with bloody diarrhea. *C*. *jejuni* F38011 strain has been shown to efficiently colonize chickens and cause disease in piglets and mice \[[@pone.0118533.ref017]--[@pone.0118533.ref019]\]. To better understand the genomic content and proteomic capacity of this strain compared to other *C*. *jejuni* strains, we have sequenced the genome and determined the proteome of the *C*. *jejuni* F38011 strain using Pacific Biosciences (PacBio) Single-Molecule Real-Time (SMRT) sequencing technology and LC-MS/MS, respectively. The results of this study demonstrate that the use of new technologies can illuminate differences between genomes and possibly uncover unique features.

Materials and Methods {#sec002}
=====================

Bacterial strains and growth conditions {#sec003}
---------------------------------------

The *C*. *jejuni* F38011 clinical strain was used throughout this study. The strain was cultured under microaerobic conditions (85% N~2~, 10% CO~2~, 5% O~2~) on Mueller-Hinton (MH) agar plates supplemented with 5% citrated bovine blood (MHB) at 37°C and passaged to a fresh plate at least once every 48 h. These conditions are optimal for *C*. *jejuni* growth. Assays were performed with *C*. *jejuni* grown on MH agar plates for 48 h and diluted in PBS.

The *C*. *jejuni* F38011 CJH00185 deletion mutant (annotated Cj0031 in NCTC 11168) was generated by double-crossover recombination. The *C*. *jejuni* NCTC 11168 Cj0031 ORF was previously annotated as two genes; however, it has been re-annotated as a single ORF at the time of this study. The PCR primers used for amplifying CJH00185 are 5'-GGGAACAAAAGCTGGAGCTCGTTTGAGTGATATAAATATATTTGATGC-3' and 5'-AAGGAACACCCGCGGTCTTTTTCATTTAGCAAAGTGAAATGC-3' to amplify the upstream fragment and 5'-CGGGCCCCCCCTCGAGGACATAAAGCAAATCCAACTAAACC-3' and 5'-CGGGCCCCCCCTCGAGGACATAAAGCAAATCCAACTAAACC-3' to amplify the downstream fragment. The chloramphenicol resistance cassette was PCR amplified using primers 5'-AAGGAACACCCGCGG-3' and 5'-GCGCAGATCCCGCGG-3' from a previously constructed pBSK vector template. The CJH00185 upstream, CJH00185 downstream, and the amplified chloramphenicol resistance cassette fragments were ligated into the pBSK-kan2 vector, which was linearized with SacI and XhoI, in a 4-way infusion reaction (Clontech Laboratories, Inc., Mountain View, CA). The upstream and downstream fragment primers contain the overlapping sequences for the cloning reaction. The resulting pBSK-kan vector, which harbors the chloramphenicol resistance cassette flanked by 5' and 3' fragments for the deletion of CJH00185, was transformed into the *C*. *jejuni* wild-type strain and chloramphenicol resistant colonies were isolated. Deletion of the CJH00185 gene in the *C*. *jejuni* CJH00185 mutant was confirmed by PCR and genomic sequence analysis.

Genome Sequencing, Methylation and Bioinformatics {#sec004}
-------------------------------------------------

DNA was isolated from the *C*. *jejuni* F38011 wild-type strain and the CJH00185 mutant following standard laboratory procedures for phenol/chloroform extraction. The DNA libraries were prepared following PacBio guidelines and sequenced on SMRT cells using Pacific Biosciences RS sequencing technology (Pacific Biosciences, Menlo Park, CA) at Washington State University. Two separate libraries were constructed for sequencing: a small fragment library used to target high quality circular consensus reads generated during polymerase strand displacement mode and a large fragment library targeting continuous long reads. Small fragments were obtained by shearing 5 μg of genomic DNA through the small orifice ruby of a Hydroshear Plus (Digilabs) for 20 cycles at speed code seven. Small fragment library preparation was performed using the Pacific Biosciences DNA Template Prep Kit 2.0 (250 bp to \< 3 kb range). Size selection and library purification was performed with 0.6X AMPure beads (Beckmann-Coulter Genomics). The resulting library had a peak size of 2.7 kb and ranged from 900 bp to 9 kb. This library was bound to C2 DNA polymerase, loaded into four SMRT cells, and polymerization was observed using two 45 min movies for each cell. Large fragment library preparation was performed by shearing 5 μg of genomic DNA using a Hydroshear large orifice ruby for 20 cycles at speed code 20. The large fragment library preparation was performed using the Pacific Biosciences DNA Template Prep Kit 2.0 (3 to 10 kb range). Size selection and library purification was performed using 0.45X AMPure beads (Beckmann-Coulter Genomics). The resulting library had a peak size of 16.5 kb and ranged from 4 to 35 kb. The large fragment library was bound to C2 DNA polymerase, mag-bead loaded into five SMRT cells, stage started, and observed using a single 2 h movie for each cell. The 13 movies generated 232k reads with an average length of 3743 bp.

Assembly was performed using the RS\_ Hierarchical Genome Assembly Process (HGAP)\_Assembly.1 protocol incorporated into SMRT Analysis v2.0. A preassembled correction contained 48 Mb of long and 628 Mb of short reads using a software calculated minimum seed read length of 9624 bp generating 4272 reads with an N50 length of 10,548 bp. The preassembled reads were assembled using Celera2.0 and polished with Quiver into two contigs with perfect circularizing overlap (1,691,939 bp and 19,277 bp). Mapping concordance of the final assembly was 99.9999. The RS_Modification_and_Motif_Analysis.1 protocol of the SMRT analysis v2.0 was used to identify methylation and the corresponding motifs of the responsible DNA methylases.

Genome annotation was performed by the National Center for Biotechnology Information (NCBI) Prokaryotic Genomes Automatic Annotation Pipeline and is published as *Campylobacter jejuni* F38011 with 'CJH' locus tags (BioSubmission: SUB358967; BioProject ID: PRJNA222831). The *C*. *jejuni* F38011 genome was visualized using CGView \[[@pone.0118533.ref020]\]. *C*. *jejuni* F38011 and NCTC 11168 genomic DNA sequences (accession number 700819) were compared using Artemis Comparison Tool (ACT), as described elsewhere \[[@pone.0118533.ref021]\]. Consensus sequence logos were created as described elsewhere \[[@pone.0118533.ref022]\].

Proteomic Analysis {#sec005}
------------------

A *C*. *jejuni* whole cell lysate was digested with trypsin. The resulting peptides were analyzed by LC-MS/MS, using a Waters nanoAcquity UPLC coupled to a Thermo Velos-FTICR mass spectrometer \[[@pone.0118533.ref023]\]. Peptides were loaded onto a 3 cm x 100 μm inner diameter fused silica trap column packed with a stationary phase consisting of MichromMagic C18, 5 μm diameter, 200 A pore size particles (Bruker) with a flow rate of 2 μL/min of mobile phase consisting of 98% solvent A (H~2~O containing 0.1% formic acid) and 2% solvent B (ACN containing 0.1% formic acid) for 10 minutes. Peptides were then fractionated over a 60 cm x 75 μm inner diameter fused silica analytical column packed with Michrom Magic C18, 5 μm diameter, 100 A pore size particles by applying a linear gradient from 95% solvent A, 5% solvent B to 65% solvent A, 35% solvent B over 120 minutes at a flow rate of 300 nL/min. Eluting peptide ions were ionized by electrospray ionization by applying a positive 2 kV potential to a laser pulled spray tip at the end of the analytical column. The Velos-FTICR mass spectrometer was operated using data dependent method consisting of a high resolution MS^1^ measurement in the ICR cell at 50K resolving power followed by low resolution MS^2^ scans in the ion trap on the 20 most intense ions with charge state of 2+ or greater. MS^2^ settings included a normalized collision energy of 35, and isolation width of 2 *m/z*, and an activation time of 10 ms. Ions selected for MS2 were placed on a dynamic exclusion list for 45 seconds. A total of four biological samples were analyzed in triplicate.

Tandem mass spectra data were searched against a protein database for *C*. *jejuni* strain 11168 (UniProt entry CAMJE) containing forward and reverse sequences (3246 total protein sequences) as well as a database containing forward and reverse sequences for *C*. *jejuni* strain F38011 (3368 total protein sequences), using SEQUEST (version UWPR2012.01). SEQUEST search parameters included: consideration of only fully tryptic peptide sequences, a 25 ppm precursor ion mass tolerance, a 0.36 Da fragment ion mass tolerance, the static modification of carbamidomethylation of Cys residues (57.021464 Da), and the variable modification of oxidation on Met residues (15.9949 Da). A 1% false discovery rate (FDR) threshold was applied to the resulting peptide spectrum matches. All proteins were analyzed and sorted based on subcellular locations using PSORTb v.2.0 \[[@pone.0118533.ref024]\]. Enzymatic functional class annotations were obtained from the UniProt database for 485 enzymes identified in this study \[[@pone.0118533.ref025]\].

Tissue culture {#sec006}
--------------

INT 407 human intestinal epithelial cells (ATCC CCL6; American Type Culture Collection, Manassas, VA, USA) were cultured as previously described \[[@pone.0118533.ref026]\].

Binding and internalization assays {#sec007}
----------------------------------

Determination of *C*. *jejuni* adherence and internalization by INT 407 cells was assessed as previously described \[[@pone.0118533.ref027]\]. Assays were performed using a multiplicity of infection of 50--500 and reproduced at least 3 times. Statistical analyses were performed using GraphPad Prism 6 (La Jolla, CA. USA) and statistical significance (*P* ≤ 0.05) was determined by one-way analysis of variance (ANOVA) using Tukey's post-test.

Growth characterization of *C*. *jejuni* strains and survival in deoxycholate (DOC) {#sec008}
-----------------------------------------------------------------------------------

Overnight MHB plate cultures of *C*. *jejuni* strains were used to inoculate fresh MH broth, with and without 0.05% DOC concentration, at an OD~540~ of 0.01 and bacterial density was monitored at the indicated time points using a spectrophotometer. Survival was assessed by plating 10-fold serial dilutions of the broth cultures on MHB plates, at the indicated time points, and colonies were counted to determine CFU/ml. Statistical analyses were performed using GraphPad Prism 6 and statistical significance (*P* ≤ 0.05) was determined by ANOVA using Tukey's post-test.

Results and Discussion {#sec009}
======================

The *C*. *jejuni* F38011 clinical strain (biotype I, serotype 90) was isolated from an individual with bloody diarrhea \[[@pone.0118533.ref028], [@pone.0118533.ref029]\]. Given that this *C*. *jejuni* strain has been used for more than two decades to dissect the virulence proteins and associated factors necessary for *Campylobacter* pathogenesis, we sought to more fully characterize this strain. The genome of the *C*. *jejuni* F38011 strain was sequenced using Pacific Biosciences sequencing technology. The *C*. *jejuni* F38011 genome was determined to be 1.69 Mb (1,691,939) with 1613 predicted protein coding sequences (CDSs) ([Fig. 1](#pone.0118533.g001){ref-type="fig"}). The genome was sequenced with 100% of bases called, forming a single circular genome from library preparation (99.9999% consensus accuracy) and average nucleotide coverage of 396. No plasmids were identified. The mol.% (G+C) content was 30.5% and the change in GC skew demonstrates origin of replication for the *C*. *jejuni* F38011 strain, as observed elsewhere \[[@pone.0118533.ref030]\]. Genomic regions associated with the largest changes in mol.% (G+C) content reflect points in the genome encoding tRNAs or rRNAs. Using the Artemis Comparison Tool (ACT), the genomes of the *C*. *jejuni* F38011 and NCTC 11168 strains were compared ([Fig. 2](#pone.0118533.g002){ref-type="fig"}). *C*. *jejuni* NCTC 11168 is 1.6 Mb (1,641,481) with a mol.% (G+C content) of 30.5% \[[@pone.0118533.ref031]\]. There is substantial synteny between strains and similarity in mol.% (G+C) content, even though the *C*. *jejuni* F38011 genome is greater in size. Furthermore, the *C*. *jejuni* F38011 strain contained 122 putative CDSs with little similarity to genes found in NCTC 11168 strain; however, the *C*. *jejuni* F38011 strain also lacked 58 CDSs present in the NCTC 11168 genome ([S1 Table](#pone.0118533.s003){ref-type="supplementary-material"}). Many of the CDSs unique to either strain fall within the hypervariable plasticity regions of the organism, as discussed below. Additionally, the *C*. *jejuni* F38011 strain does not harbor plasmids that confer resistance to antibiotics, including the tetracycline resistance plasmid found in *C*. *jejuni* 81--176 (pTet plasmid) \[[@pone.0118533.ref032]\].

![Genomic map of the *C*. *jejuni* F38011 strain.\
A 1.69 Mbp circular chromosome of the *C*. *jejuni* F38011 strain, beginning with DnaA and encoding a putative 1613 CDSs. Direction of the predicted protein coding sequences (CDS), transfer RNAs (tRNA), ribosomal RNAs (rRNA), mol.% (G+C) content, and GC skew are indicated.](pone.0118533.g001){#pone.0118533.g001}

![The *C*. *jejuni* F38011 genome shares similarity to the NCTC 11168 genome.\
Panel A) Analysis of the *C*. *jejuni* F38011 and NCTC 11168 genomes using Artemis Comparison Tool (ACT) shows the gene order and organization of the *C*. *jejuni* F38011 genome is similar to the NCTC 11168 strain. Blocks of similarity are indicated with red and inversions are indicated with blue between strains. Panel B) Comparison of the seven hypervariable plasticity regions (PR1---PR7) in the genomes of the *C*. *jejuni* F38011 and NCTC 11168 strains. Genes are shown in blue with the gray bar below each PR indicating the gap fraction of pairwise alignment with black columns representing absence of genetic information in the *C*. *jejuni* F38011 strain. PR parameters were determined as described elsewhere \[[@pone.0118533.ref033]\].](pone.0118533.g002){#pone.0118533.g002}

The pan genome, which is comprised of both the core and variable genes, was evaluated in the *C*. *jejuni* F38011 strain. Previous comparative genomic hybridization analysis using microarrays to assess the genomic content of 11 *C*. *jejuni* clinical isolates identified the common or core genes despite extensive genetic variability between isolates \[[@pone.0118533.ref034]\]. The common genes, which were nearly 84% of the total genes, encoded proteins involved in metabolic, biosynthetic, cellular, and regulatory processes. The regions of the genome that were variable included genes encoding the biosynthesis and modification of the flagella, LOS and capsular polysaccharide. It was later determined that the variable regions were generally found in seven clusters termed hypervariable plasticity regions (PR; PR1---PR7) \[[@pone.0118533.ref033]\]. The genetic content of PR1 encodes proteins associated with molybdenum reduction and transport and biotin synthesis; PR2 contains putative membrane transporters and hypothetical proteins; PR3 contains ABC transporters, membrane, and hypothetical proteins; PR4 encodes N-Acetyl Neuraminic Acid (NANA) synthase genes; PR5 contains components of the LOS biosynthesis and flagellar genes (including posttranslational modification); PR6 harbors components responsible for capsule biosynthesis; and PR7 contains genes that encode membrane proteins. Using the PR parameters determined by Pearson and colleagues \[[@pone.0118533.ref033]\], we compared each variable region of the *C*. *jejuni* F38011 strain to the *C*. *jejuni* NCTC 11168 strain ([Fig. 2](#pone.0118533.g002){ref-type="fig"}). While PR1, PR2, PR3 were nearly identical between these two *C*. *jejuni* strains, differences were observed in PR4, PR5, PR6, and PR7. Others have also observed considerable genomic diversity between *C*. *jejuni* isolates recovered from a similar biological source \[[@pone.0118533.ref035], [@pone.0118533.ref036]\]. Additional research is needed to assess the contribution of the gene products located within these hypervariable regions to the phenotypic variation, microbial adaptation to an environmental niche, and/or an isolate's virulence.

Methylation motifs in the *C*. *jejuni* F38011 genome {#sec010}
-----------------------------------------------------

PacBio sequencing is a reliable and robust method to determine modified bases due to changes in the kinetics of the DNA polymerase as it incorporates the appropriate nucleotide opposite a modified base \[[@pone.0118533.ref037]\]. DNA methylation was determined in the *C*. *jejuni* F38011 strain using the PacBio RS sequencing platform and total base modifications were detected during SMRT sequencing. The modified bases were clustered into five consensus sequences (plus additional modified bases that were not clustered) and were distributed throughout the genome ([Fig. 3](#pone.0118533.g003){ref-type="fig"}). The motifs identified were consistent with two types of methylation: four motifs are recognized by ^m6^A methyltransferases (N-6 adenine-specific DNA methylases) and a single motif is recognized by ^m4^C methyltransferases (N-4 cytosine-specific DNA methylases). Motifs 1, 3 and 4 contained bases methylated on both strands, whereas bases on motifs 2 and 5 were modified on only one strand at each site. The dominant ^m6^A methylation motifs were abundant and nearly completely methylated, as the percent of methylated motifs detected range from 99.5 to 100% for motifs 1, 2, 3 and 4. The ^m4^C modification (motif 5) had a consensus sequence of ANNNNCGNAAATTY and was methylated on 34 of 77 motifs (44.2% percent of motifs detected). The mean modification quality value (QV = 122) and the mean coverage was 188, which is necessary for a confident base modification call at this level of coverage ([Table 1](#pone.0118533.t001){ref-type="table"}). However, because the modification signatures can vary due to the dynamic nature of the kinetic signal, we cannot rule out the possibility that Motif 5 is a false positive motif overcalled by PacBio software, as described elsewhere \[[@pone.0118533.ref038]\].

![The methylome of *C*. *jejuni* F38011 contains 5 dominant methylation motifs.\
The methylation consensus sequences identified by PacBio with adenine methylations found in motifs 1, 2, 3, and 4 (motifs 1, 2 and 4 have a partner motif; RAATTY partner motif not shown) and cytosine methylation found in motif 5. Consensus sequences for each motif is represented as logos, where the height of each stack indicates conservation of sequence (bits) and the height of the symbols represent the relative frequency of the base. An asterisk below a base indicates the modified nucleotide in each consensus sequence. The consensus sequence on the circular genome is indicated with a black line. The numbers within each genome represent methylated sequences compared to the total number of each identified consensus sequence.](pone.0118533.g003){#pone.0118533.g003}

10.1371/journal.pone.0118533.t001

###### Methylation motif analysis of *C*. *jejuni* F38011 wild-type isolate, as assessed by PacBio sequencing.

![](pone.0118533.t001){#pone.0118533.t001g}

  Motif   Consensus Sequence   Modified Position   Modification Type   \% Motifs Detected   \# of Motifs Detected   \# of Motifs in Genome   Mean Modification QV   Mean Motif Coverage   Partner Motif
  ------- -------------------- ------------------- ------------------- -------------------- ----------------------- ------------------------ ---------------------- --------------------- -----------------
  1       RAATTY               3                   ^m6^A               99.74                27986                   28058                    251.3                  167                   RAATTY
  2       GKAAYC               4                   ^m6^A               100                  820                     820                      274.6                  179.4                 
  3       GAGNNNNNRTG          2                   ^m6^A               99.73                752                     754                      238.9                  181.3                 CAYNNNNNCTC
  4       CTANNNNNNNNTAYC      3                   ^m6^A               100                  206                     206                      267.7                  191.9                 GRTANNNNNNNNTAG
  5       ANNNNCGNAAATTY       6                   ^m4^C               40.26                31                      77                       122                    188.1                 
          *Not Clustered*      0                                       0.47                 16068                   3398079                  43.9                   191.5                 

The *C*. *jejuni* F38011 strain genome was assessed by REBASE ([www.rebase.neb.com](http://www.rebase.neb.com)) to determine putative *C*. *jejuni* F38011 enzymes (Cje) involved with each motif and for comparisons with known modification systems ([Table 2](#pone.0118533.t002){ref-type="table"}). Motif 1 (RAATTY) identified in the *C*. *jejuni* F38011 genome is associated with a Type II restriction-modification system common to Gram-positive and Gram-negative bacteria. REBASE analysis indicated that the RM enzyme pair CjeF38011P and M.CjeF38011I is predicted to be responsible for RAATTY modification. Motif 3 (GAGNNNNNRTG) has been identified in *C*. *jejuni* strain RFL1 and is digested by the restriction enzyme CjuII. The Type II RM system responsible for Motif 3 likely consists of CjeF38011ORFDP, based on 87% identity to CjeNII. Motif 4 (CTANNNNNNNNTAYC) is a Type I RM and predicted to be modified by the RM enzymes CjeF38011IIP, S.CjeF38011II, and M.CjeF38011II. Motifs 2 (GKAAYC) and 5 (ANNNNCGNAAATTY) are both predicted to be part of the Type II restriction modification system. CjeF38011ORFCP is the likely gene candidate responsible for modification at the consensus sequence GKAAYC based on 98% identity to CjeNIII (GKAAYG). There are two candidate enzymes that may be responsible for modification at Motif 5 (ANNNNCGNAAATTY): 1) M.CjeF38011ORFEP and 2) CjeF38011ORFAP. M.CjeF38011ORFEP shares 98.9% amino acid identity with CJE0220 from *C*. *jejuni* RM1221, as judged by BLAST analysis, and is annotated as a DNA adenine methylase (<http://microbesonline.org/>). The second candidate enzyme, CjeF38011ORFAP, shares similarity with Cj0031 (originally designated Cj0031/Cj0032) from *C*. *jejuni* NCTC 11168 that contains a hypervariable homopolymeric tract. CjeF38011ORFAP may or may not be a member of a new class of split DNA methyltransferases \[[@pone.0118533.ref039]\] (Dr. Richard J. Roberts, personal communication). The split DNA methyltransferases usually consist of 2 or 3 subunit enzymes necessary for full activity, although there is evidence that they demonstrate partial activity with just one subunit \[[@pone.0118533.ref040]\]. Furthermore, there are members of this family that are not split and are single polypeptide enzymes including CjeFV, which recognizes GGRCA but only as a methylase \[[@pone.0118533.ref041]\].

10.1371/journal.pone.0118533.t002

###### Putative *C*. *jejuni* F38011 Restriction Modification systems.

![](pone.0118533.t002){#pone.0118533.t002g}

  Type   Gene   Enzyme Name        Predicted Recognition Sequence   Genome Coordinates   CDS
  ------ ------ ------------------ -------------------------------- -------------------- ----------
  I      R      CjeF38011IIP       CTANNNNNNNNTAYC                  1527342--1529651     Cjh08075
  I      S      S.CjeF38011II      CTANNNNNNNNTAYC                  1532872--1534065     Cjh08090
  I      M      M.CjeF38011II      CTANNNNNNNNTAYC                  1535256--1536740     Cjh08100
  II     RM     CjeF38011ORFAP     ANNNNCGNAAATTY                   46431--49921         Cjh00185
  II     R      CjeF38011IP        RAATTY                           210217--210489       Cjh01080
  II     M      M.CjeF38011I       RAATTY                           210489--211592       Cjh01085
  II     RM     CjeF38011ORFCP     GKAAYC                           651959--655711c      Cjh03470
  II     RM     CjeF38011ORFDP     GAGNNNNNRTG                      992549--996643c      Cjh05290
  II     M      M.CjeF38011ORFEP   ANNNNCGNAAATTY                   1361489--1362409c    Cjh07145
  IV     R      CjeF38011McrBP                                      143327--145267       Cjh00710
  IV     R      CjeF38011McrCP                                      145254--146591       Cjh00715

Presence of the ANNNNCGNAAATTY motif in *C*. *jejuni* strains and analysis of the CJH00185 sequence {#sec011}
---------------------------------------------------------------------------------------------------

REBASE predicted that the gene CJH00185 (CjeF38011ORFAP) is one of two putative Type IIG methylases in *C*. *jejuni* F38011 that could be responsible for DNA methylation of the N-4 cytosine (^m4^C) at the ANNNNCGNAAATTY motif. All of these sites also contain the RAATTY motif. Considering this ^m4^C motif was previously not recognized in *C*. *jejuni* as a site of DNA methylation, we first inspected the genomes of three additional *C*. *jejuni* strains (NCTC 11168, 81--176, and RM1221) for the presence of the ^m4^C methylated motif. The *C*. *jejuni* NCTC 11168 and 81--176 strains were recovered from the stools of individuals with campylobacteriosis whereas the *C*. *jejuni* RM1221 strain was recovered from the skin of a chicken \[[@pone.0118533.ref042]--[@pone.0118533.ref044]\]. All three *C*. *jejuni* strains shared 23 of the 34 genomic regions associated with the ^m4^C motif in the *C*. *jejuni* F38011 strain ([Table 3](#pone.0118533.t003){ref-type="table"}). The only ^m4^C site that was unique to the *C*. *jejuni* F38011 genome was associated with a hypothetical protein (CJH01365).

10.1371/journal.pone.0118533.t003

###### ^m4^C Methylation motif (ANNNNCGNAAATTY) associated with CDSs in 4 *C*. *jejuni* strains.

![](pone.0118533.t003){#pone.0118533.t003g}

  F38011 CDS                                      F38011   NCTC11168   81176   RM1221
  ----------------------------------------------- -------- ----------- ------- --------
  Cjh01365                                        X                            
  Cjh03960                                        X        x                   
  Cjh07705                                        X        x                   
  Cjh04175                                        X        x                   x
  Cjh02885                                        X        x           x       
  Cjh06100                                        X        x           x       x
  Cjh00635                                        X        x           x       x
  Cjh01015                                        x        x           x       x
  Cjh08650                                        x        x           x       x
  Cjh06140                                        x        x           x       x
  Cjh04030                                        x        x           x       x
  Cjh00185[\*](#t003fn001){ref-type="table-fn"}   x        x           x       x
  Cjh000480                                       x        x           x       x
  Cjh00975                                        x        x           x       x
  Cjh04615                                        x        x           x       x
  Cjh03835                                        x        x           x       x
  Cjh01715                                        x        x           x       x
  Cjh04960                                        x        x           x       x
  Cjh03470                                        x        x           x       x
  Cjh04685                                        x        x           x       x
  Cjh05175                                        x        x           x       x
  Cjh02615                                        x        x           x       x
  Cjh00950                                        x        x           x       x
  Cjh02975                                        x        x           x       x
  Cjh08880                                        x        x           x       x
  Cjh03400                                        x        x           x       x
  Cjh08420                                        x        x           x       x
  Cjh03600                                        x        x           x       x
  Cjh01665                                        x                    x       x
  Cjh01310                                        x                    x       x
  Cjh02300                                        x                    x       x
  Cjh04945                                        x                    x       x
  Cjh09850                                        x                    x       
  Cjh02865                                        x                    x       

\* Indicates putative enzyme responsible for m4C modifications

Inspection of the CJH00185 sequence revealed a frameshift mutation within the 3491 nucleotides that splits the sequence into two ORFs and could prevent the translation of the full-length CDS of the CjeF38011ORFAP ([S1 Fig](#pone.0118533.s001){ref-type="supplementary-material"}.). Noteworthy is that the Cj0031 gene of *C*. *jejuni* NCTC 11168, which is a putative homologue of CJH00185, contains a hypervariable homopolymeric tract \[[@pone.0118533.ref041]\]. In contrast to the Cj0031 gene that has a polymorphic poly-G tract within the CDS (8--10 bases), we identified a tract of four bases in a similar location within the CJH00185 gene.

Proteomic analysis of the *C*. *jejuni* F38011 strain {#sec012}
-----------------------------------------------------

Total protein was assessed in the *C*. *jejuni* F38011 strain to determine the putative restriction-modification enzymes that are synthesized. The proteins produced by the *C*. *jejuni* F38011 strain were collected after 48 h growth in rich broth medium and analyzed by LC-MS/MS. A total of 1336 proteins (82% of the 1613 predicted CDSs) were identified when mapped to *C*. *jejuni* NCTC 11168 (listed in [S2](#pone.0118533.s004){ref-type="supplementary-material"} and [S3](#pone.0118533.s005){ref-type="supplementary-material"} Tables). Interestingly, peptides matched uniquely to more than 30 CDSs in the *C*. *jejuni* F38011 database compared to NCTC 11168 ([S3 Table](#pone.0118533.s005){ref-type="supplementary-material"}). Only the proteins with peptides identified at less than 1% false discovery rate were included in the analysis. The identified proteins were assessed by the PSORTb v.2.035 program (<http://www.psort.org/psortb/index.html>) to classify subcellular locations. The subcellular localization of proteins was predicted to group into three major classes: cytoplasmic proteins (53%), cytoplasmic membrane proteins (21%), and proteins of unknown location (21%) ([Fig. 4](#pone.0118533.g004){ref-type="fig"}). Comparing the 1336 proteins identified against the UniProt entry for the *C*. *jejuni* 11168 strain, we identified 485 enzymes that were grouped into six functional classes, with transferases (34%) representing the most abundant group ([Fig. 4](#pone.0118533.g004){ref-type="fig"}).

![Analysis of the proteins synthesized by *C*. *jejuni* F38011.\
Panel A) Full proteomic analysis of *C*. *jejuni* F38011 proteins identified by LC-MS/MS analysis that scored greater than the 1% false discovery rate (FDR) arranged by subcellular localization, as assessed by PSORT. Panel B) Analysis of 485 enzymes grouped by functional classes synthesized by *C*. *jejuni* F38011, as derived from UniProt.](pone.0118533.g004){#pone.0118533.g004}

Consistent with the results of genomic sequence and methylation profiles, peptide fragments corresponding to the *C*. *jejuni* putative RM enzymes ([Table 2](#pone.0118533.t002){ref-type="table"}) were identified by LC-MS/MS. For example, four peptide fragments corresponding to the deduced amino acid sequence of CjeF38011ORFAP protein were detected ([S3 Table](#pone.0118533.s005){ref-type="supplementary-material"}). However, the CjeF38011ORFAP peptide fragments identified were localized within the amino-terminal region of the CDS ([S1 Fig](#pone.0118533.s001){ref-type="supplementary-material"}.). While this finding indicates that CJH00185 is expressed and a protein is synthesized, it is not possible to determine the true CDS from the LC-MS/MS analysis. In summary, the LC-MS/MS data indicates that the RM enzymes listed in [Table 2](#pone.0118533.t002){ref-type="table"} are synthesized.

Preliminary characterization of a *C*. *jejuni* F38011 CJH00185 deletion mutant {#sec013}
-------------------------------------------------------------------------------

We chose to assess the contribution of the gene CJH00185, as it is predicted to encode a putative Type II RM methylase. A *C*. *jejuni* CJH00185 mutant was constructed in which the entire CDS was deleted and the mutant was analyzed by PacBio sequencing. The *C*. *jejuni* CJH00185 mutant mapped to the wild-type reference strain at all positions (except where the gene deletion occurred), with 100% of bases called with 99.99% consensus accuracy and an average nucleotide coverage of 342.4. Interestingly, the modified bases found in the mutant clustered into only four consensus sequences ([Table 4](#pone.0118533.t004){ref-type="table"}). Specifically, PacBio SMRT analysis did not identify modified bases corresponding to motif 5 in the CJH00185 mutant. However, based on the data in-hand, we cannot rule out the possibility that the PacBio SMRT analysis failed to identify motif 5 in the *C*. *jejuni* CJH00185 mutant due to the relative difficulty in identifying partially methylated DNA.

10.1371/journal.pone.0118533.t004

###### Methylation motif analysis of *C*. *jejuni* F38011 ΔCjh_00185 mutant, as assessed by PacBio sequencing.

![](pone.0118533.t004){#pone.0118533.t004g}

  Motif   Consensus Sequence   Modified Position   Modification Type   \% Motifs Detected   \# of Motifs Detected   \# of Motifs in Genome   Mean Modification QV   Mean Motif Coverage   Partner Motif
  ------- -------------------- ------------------- ------------------- -------------------- ----------------------- ------------------------ ---------------------- --------------------- -----------------
  1       RAATTY               3                   m6A                 99.28                27603                   27804                    213.5                  158.1                 RAATTY
  2       GKAAYC               4                   m6A                 99.63                810                     813                      228.6                  160.8                 
  3       GAGNNNNNRTG          2                   m6A                 98.78                729                     738                      205.5                  164.2                 CAYNNNNNCTC
  4       CTANNNNNNNNTAYC      3                   m6A                 99.51                205                     206                      222.8                  167.2                 GRTANNNNNNNNTAG
          *Not Clustered*      0                                       0.26                 8739                    3353373                  42.7                   167.5                 

Although many ^m4^C modifications protect bacteria from foreign DNA, the majority of ^m4^C modifications do not have known biological roles \[[@pone.0118533.ref045]\]. We initially hypothesized that ^m4^C methylation could play a role in gene regulation. However, the methyl-cytosine consensus sequence was distributed throughout the entire genome without statistical correlation to the nearest putative methionine initiation codon ([Fig. 5](#pone.0118533.g005){ref-type="fig"}). Therefore, we have no evidence for methylation altering gene expression in *C*. *jejuni*. Another possibility is that the methylation influences *C*. *jejuni* fitness, as has been shown for *Brucella*, *Escherichia coli*, *Haemophilus*, *Salmonella*, *Vibrio*, and *Yersinia* \[[@pone.0118533.ref016]\]. To test this possibility, several phenotypic assays were performed. Malik-Kale and colleagues identified a set of *C*. *jejuni* genes upregulated in the presence of a physiologically relevant concentration of the bile acid DOC \[[@pone.0118533.ref046]\]. More specifically, microarray data from *C*. *jejuni* grown in the presence of DOC revealed that multiple genes were upregulated compared to growth without DOC \[[@pone.0118533.ref046]\]. *C*. *jejuni* inoculation of growth medium supplemented with DOC increases the kinetics of cellular invasion and increases the secretion and delivery of key virulence proteins to the cytosol of host cells, as compared to growth in non-supplemented growth medium. Thus, we characterized the *C*. *jejuni* CJH00185 deletion mutant in assays with and without physiological concentrations of DOC (0.05%) and determined whether this mutant is capable of binding to and invading epithelial cells. Bacterial growth rates were similar between strains in MH broth with and without 0.05% DOC ([S2 Fig](#pone.0118533.s002){ref-type="supplementary-material"}.). Bacterial survival over time was also similar between strains in MH broth with and without 0.05% DOC, as determined by CFU analysis ([S2 Fig](#pone.0118533.s002){ref-type="supplementary-material"}.). Furthermore, adherence to and invasion of INT 407 cells by *C*. *jejuni* following 30 and 180 min incubation period, respectively, demonstrated no statistical difference between the wild-type and the mutant isolate ([S2 Fig](#pone.0118533.s002){ref-type="supplementary-material"}.). Thus, the *C*. *jejuni* F38011 CJH00185 mutant is phenotypically indistinguishable from the wild-type strain in these assays.

![Genomic sites of methyl-cytosine modification is not correlated near putative methionine initiation codons.\
The methyl-cytosine consensus sequence is distributed throughout the genome with no correlation of proximity near the putative methionine initiation codon.](pone.0118533.g005){#pone.0118533.g005}

Summary {#sec014}
-------

The goal of this study was to analyze the genomic content, methylome profile, and proteomic capacity of the *C*. *jejuni* F38011 clinical strain *to gain insight into* microbial processes. In this study, we have further characterized the *C*. *jejuni* F38011 strain using PacBio\'s SMRT sequencing coupled with methylome analysis. While this sequencing method provides insight into the DNA methylation status of the *C*. *jejuni* genome, additional work is necessary to confirm the observation of the ^m4^C modification. Nonetheless, peptides corresponding to all of the enzymes predicted to be responsible for methylation in *C*. *jejuni* were detected using proteomic analysis. This study provides the foundation for studies to determine the functions of the putative restriction-modification enzymes in *C*. *jejuni*.

Supporting Information {#sec015}
======================

###### Diagram of the *C*. *jejuni* F38011 CJH00185 CDS (CjeF38011ORFAP enzyme).

The putative CJH00185 gene is 3491 base pairs (bp) with a frameshift mutation at position 1989 that splits the sequence into two ORFs (light gray and dark gray boxes). The consensus sequences for the modified bases (^m4^C sites) are indicated.

(TIF)

###### 

Click here for additional data file.

###### The *C*. *jejuni* F38011 CJH00185 mutant demonstrates characteristics indistinguishable from the wild-type isolate.

Panel A) Bacterial growth rates in broth are similar between strains in MH broth with and without 0.05% DOC. Panel B) Bacterial survival over time is similar between strains in MH broth with and without 0.05% DOC, as determined by CFU analysis. Panel C) Invasion of INT 407 cells by *C*. *jejuni* following incubation with INT 407 cells for 30 and 180 min. There was no statistical difference in initial bacterial binding to cells between strains.

(TIF)

###### 

Click here for additional data file.

###### Unique predicted protein coding sequences (CDSs) between *C*. *jejuni* strains F38011 and NCTC 11168.

(XLSX)

###### 

Click here for additional data file.

###### UniProt proteomic analysis of *C*. *jejuni* F38011 peptides mapped to *C*. *jejuni* NCTC 11168 (CAMJE).

(XLSX)

###### 

Click here for additional data file.

###### Sequest peptides corresponding to *C*. *jejuni* F38011, as determined by LC-MS/MS.

(XLSX)

###### 

Click here for additional data file.
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